Catalio Capital Seeks $500 Million for AI Healthcare Fund

The firm is targeting new capital to accelerate the development of artificial intelligence solutions in the medical sector.

Updated on Oct. 15, 2026 in Healthcare

Isometric editorial illustration of a steel centrifuge rotor and a microchip wafer on a clinical surface, representing medical technology investment. — Catalio Capital Management is seeking to raise $500 million for a new fund targeting early-stage companies at the intersection of AI and healthcare. AI Illustration. Upload story photo >

Live Poll

Do you believe increased investment in healthcare AI will lead to better results for patients?

Catalio Capital Management is seeking to raise $500 million to invest in artificial intelligence healthcare startups. This move marks the firm's second capital raise in 16 months and focuses on the intersection of AI technology and clinical innovation.

Why it matters

The capital injection targets the accelerated pace of innovation driven by artificial intelligence in the medical sector. For operators, this indicates strong institutional appetite for AI-integrated healthcare solutions that promise to shift operational efficiencies and care delivery models.

Catalio Capital Management is aiming for a $500 million fund to support AI-driven healthcare startups. The firm is backed by KKR & Co. and follows a previous fundraising event completed 16 months prior.

The players

Catalio Capital Management

An investment firm focused on funding emerging technologies and healthcare innovation.

KKR & Co.

A global alternative asset manager that provides capital backing for private equity and investment strategies.

The details

The investment strategy centers on leveraging artificial intelligence to expedite healthcare innovation. By providing specialized capital to early-stage technology companies, the fund aims to scale solutions that integrate machine learning into clinical workflows or diagnostic processes. The involvement of KKR & Co. suggests a broader institutional effort to institutionalize AI-driven care improvements across the sector.

The firm completed its previous fundraise in June 2025.
The current $500 million fundraise was initiated in October 2026.

Market Landscape

This effort aligns with a documented industry-wide shift toward high-capital allocation for artificial intelligence in healthcare. It extends the trend of venture-backed innovation cycles where firms seek to capitalize on the rapid integration of machine learning into medical systems.

Operators in the healthcare space should monitor this capital influx as a signal of upcoming product launches or potential consolidation in the AI startup market. Keep track of emerging technologies that may impact your operational efficiency or competitive stance over the next 12 to 24 months.

The takeaway

The sustained interest in AI-healthcare startups underscores a shift toward technology-led patient and administrative outcomes. Evaluate your own internal workflows to identify whether adopting or partnering with these AI-native solutions could offer a competitive edge in your specific market segment.